Rivernorth Capital Management’s Eagle Growth and Income Opportunities Fund EGIF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-207,900
Closed -$2.61M 495
2020
Q3
$2.61M Sell
207,900
-197,270
-49% -$2.49M 0.16% 118
2020
Q2
$5.47M Buy
405,170
+252,633
+166% +$3.07M 0.31% 83
2020
Q1
$1.62M Buy
152,537
+125,476
+464% +$1.91M 0.11% 161
2019
Q4
$461K Buy
+27,061
New +$434K 0.03% 213
2019
Q3
Sell
-215,886
Closed -$3.32K 275
2019
Q2
$3.32K Sell
215,886
-12,104
-5% -$186K 0.14% 97
2019
Q1
$3.5M Sell
227,990
-413,716
-64% -$6.06M 0.23% 92
2018
Q4
$8.1M Buy
641,706
+24,201
+4% +$344K 0.48% 61
2018
Q3
$9.38M Buy
617,505
+82,161
+15% +$1.28M 0.78% 38
2018
Q2
$8.23M Buy
535,344
+158,473
+42% +$2.42M 0.65% 45
2018
Q1
$5.66M Buy
376,871
+85,196
+29% +$1.36M 0.42% 69
2017
Q4
$4.84M Buy
+291,675
New +$4.83M 0.34% 79

Rivernorth Capital Management's EGIF Position: Q4 2020 in Review

Rivernorth Capital Management sold out of Eagle Growth and Income Opportunities Fund (EGIF) in Q4 2020, closing a stake of 207,900 shares — an estimated $2.61M sold.

Rivernorth Capital Management first reported a position in EGIF in Q4 2017 and held it in 11 quarters. The position peaked at $9.38M in Q3 2018. 0 funds tracked by Wall St. Rank hold EGIF as of Q4 2020.

  • Rivernorth Capital Management reported no remaining Eagle Growth and Income Opportunities Fund position as of Q4 2020 after selling out during the quarter.
  • Rivernorth Capital Management sold 207,900 Eagle Growth and Income Opportunities Fund shares in Q4 2020, an estimated $2.61M.
  • Rivernorth Capital Management first reported a position in Eagle Growth and Income Opportunities Fund in Q4 2017 and held it in 11 quarters.
  • Rivernorth Capital Management's Eagle Growth and Income Opportunities Fund position peaked at $9.38M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Eagle Growth and Income Opportunities Fund as of Q4 2020.

Based on Rivernorth Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.